Waters Parkerson & Co., LLC Bristol Myers Squibb CO Transaction History

Waters Parkerson & Co., LLC

$1.82 Billion
Q4 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 12,005 shares of BMY stock, worth $670,239. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,005

Previous 12,005 -0.0%

Holding current value

$670,239

Previous $621,000 9.34%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $19,830 - $25,875	-500 Reduced 4.0%	12,005 $621,000
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $3,220 - $4,239	-80 Reduced 0.64%	12,505 $519,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $403,032 - $456,960	-8,400 Reduced 40.03%	12,585 $682,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $98,850 - $117,956	2,039 Added 10.76%	20,985 $1.08 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $17,367 - $19,419	-300 Reduced 1.56%	18,946 $1.1 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $65,939 - $73,215	-1,035 Reduced 5.1%	19,246 $1.23 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $5,585 - $6,335	-85 Reduced 0.42%	20,281 $1.41 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $767,713 - $894,973	-14,315 Reduced 41.28%	20,366 $1.27 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $20,554 - $22,383	-332 Reduced 0.95%	34,681 $2.32 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $53,406 - $60,065	-900 Reduced 2.51%	35,013 $2.21 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $34,644 - $39,258	600 Added 1.7%	35,913 $2.23 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $81,148 - $89,923	-1,413 Reduced 3.85%	35,313 $2.13 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $8,223 - $9,613	-150 Reduced 0.41%	36,726 $2.16 Million
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $64,588 - $93,862	1,392 Added 3.92%	36,876 $2.06 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $25,441 - $33,186	-517 Reduced 1.44%	35,484 $2.28 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $42,513 - $50,405	-994 Reduced 2.69%	36,001 $1.83 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $78,085 - $86,345	1,750 Added 4.97%	36,995 $1.68 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $133,735 - $159,463	-2,964 Reduced 7.76%	35,245 $1.68 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $30,816 - $39,961	-632 Reduced 1.63%	38,209 $1.99 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $18,433 - $20,791	-334 Reduced 0.85%	38,841 $2.41 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $45,578 - $56,807	-902 Reduced 2.25%	39,175 $2.17 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $71,604 - $82,431	-1,195 Reduced 2.9%	40,077 $2.54 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $27,615 - $31,870	500 Added 1.23%	41,272 $2.63 Million
Q2 2017 Aug 11, 2017	BUY	N/A	40,772	40,772 $2.27 Million

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Bristol Myers Squibb CO Transaction History